Cargando…

MSC-EVs transferring mitochondria and related components: A new hope for the treatment of kidney disease

Kidney disease is a serious hazard to human health. Acute or chronic renal disease will have a significant negative impact on the body’s metabolism. The involvement of mitochondria in renal illness has received a lot of interest as research on kidney disease has advanced. Extracellular vesicles are...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Jueyi, Li, Cuifang, Wu, Feifeng, She, Zhou, Luo, Senlin, Chen, Xiaoyu, Wen, Chuan, Tian, Jidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556818/
https://www.ncbi.nlm.nih.gov/pubmed/36248840
http://dx.doi.org/10.3389/fimmu.2022.978571
Descripción
Sumario:Kidney disease is a serious hazard to human health. Acute or chronic renal disease will have a significant negative impact on the body’s metabolism. The involvement of mitochondria in renal illness has received a lot of interest as research on kidney disease has advanced. Extracellular vesicles are gaining popularity as a means of intercellular communication in recent years. They have a close connection to both the nephropathy process and the intercellular transfer of mitochondria. The goal of this review is to present the extracellular vesicle transport mitochondria and its related biologically active molecules as new therapeutic options for the treatment of clinical kidney disease. This review focuses on the extracellular vesicles through the transfer of mitochondria and its related bioactive molecules, which affect mitochondrial energy metabolism, take part in immune regulation, and secrete outside the body.